Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ethanol lock therapy for catheter-related bloodstream infection in pediatric parenteral nutrition patients
NL-OMON33319Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2009
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial in catheter-associated bloodstream infection (CRBSI) comparing Ethanol lock therapy plus standard antimicrobial treatment with Heparin lock plus standard antimicrobial treatment (2 arms). Primary endpoint: Treatment failure. Planned start Feb 2009; status: not yet recruiting.
02
Drugs
ethanolheparin
03
Conditions
catheter-associated bloodstream infection (CRBSI)
Beyond the preview
Go deeper on NL-OMON33319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33319.